<DOC>
	<DOCNO>NCT01551680</DOCNO>
	<brief_summary>Recent pre-clinical clinical data indicate BSI-201 posse characteristic typical PARP inhibitor class . Based result vitro vivo study , trial aim evaluate combination BSI-201 concomitantly radiotherapy patient present multiple non operable brain metastasis . As radiotherapy local treatment target tumor , molecule BSI-201 show major toxicity tissue without DNA alteration , propose combination expect provide tumor-selective therapy lead clinical benefit improvement . Primary objective determine recommend phase II dose ( RP2D ) evaluate acute toxicity ( CTC-AE v4.0 grade scale ) concurrent administration whole brain radiotherapy ( WBR ) small molecule BSI-201 non operable brain metastasis .</brief_summary>
	<brief_title>A Trial Evaluating Concurrent Whole Brain Radiotherapy Iniparib Multiple Non Operable Brain Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Iniparib</mesh_term>
	<criteria>Non operable brain metastasis type cancer ( ≥ 2 ) At least one measure brain target available ≥ 1 cm ( T1weighted sequence contrast application MRI ) No stereotaxie indication Any anterior treatment systemic disease ( chemotherapy line ) accept interrupt least 15 day 30 day present protocol No extrabrain disease stabilize since least 1 month Aged ≥ 18 year old KPS &gt; 70 ( RPS class I II ) Adequate bone marrow function : WBC ≥ 3.5 x 109/L , ANC ≥ 1.5 x 109/L , Platelets ≥ LLN , Hb &gt; 10g/dL , Adequate renal function : serum creatinine ≤ 1.5 × ULN blood urea nitrogen ≤ 25 mg/dL Male female patient use adequate contraceptive method Women childbearing potential must negative serum urine pregnancy test within 3 day prior start treatment Informed sign consent Able follow accord term protocol Affiliated French National social security Anterior treatment brain metastasis ( surgery , radiosurgery , stereotaxie ) Leptomeningeal metastases Inclusion another protocol within 30 day Brain metastasis severe intracranial hypertension clinical sign Other cancer except know primary tumor situ cervix cancer basocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>